Preimplantation Genetic Testing Market: Growing Demand for Genetic Screening Drives Market Growth

The global preimplantation genetic testing market is expected to expand at a CAGR of ~13% from 2023 to 2035, reaching a revenue of USD 6.72 billion by the end of 2035. The market growth is driven by the increasing number of newborns with congenital genetic disorders. Preimplantation genetic testing involves screening embryos for genetic problems prior to implantation.

Down syndrome is the most common chromosomal disorder identified in the United States, with around 6,000 cases each year. This highlights the need for early genetic testing to detect and prevent congenital genetic disorders. In addition to detecting chromosomal problems, preimplantation genetic testing also has applications in tissue typing for blood disorders.

The increasing cases of false pregnancies, miscarriages, and other factors are also contributing to the growth of the preimplantation genetic testing market. This testing method is particularly useful for women who want to screen their embryos for problems that could cause treatment failure or repeated miscarriages.

Furthermore, the high number of newborn deaths worldwide due to genetic deformities is expected to drive market growth. Preimplantation genetic testing enables early detection of defective chromosomes, helping to prevent congenital genetic deformities in fetuses.

The market is segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. The North America region is estimated to generate the largest revenue by 2035, thanks to technological advancements in genetic testing and increasing demand for assisted reproductive technologies. The European market is also expected to grow at a high rate, supported by a favorable regulatory environment and advancements in genetic testing technologies.

Overall, the preimplantation genetic testing market is experiencing significant growth due to the increasing demand for genetic screening and advancements in testing technologies. The market is expected to continue growing as awareness and acceptance of preimplantation genetic testing increases among couples and individuals seeking assisted reproductive technologies.